• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

PMD’s at-home spirometry could improve medication adherence in cystic fibrosis patients

April 21, 2017 By Sarah Faulkner

PMD HealthcarePMD Healthcare touted data today from a pediatric cystic fibrosis study which the company said demonstrates the feasibility of at-home spirometry using its Spiro PD device.

Cystic fibrosis patients take a variety of medications daily, PMD pointed out, and adherence to complicated regimens can be a challenge.

The Allentown, Penn.-based company’s study examined forced expiratory volume, body mass index and treatment burden scores of the intervention group compared to the control group.

Nearly 78% of patients surveyed in the study supported frequent monitoring of pulmonary function and 29 out of the 40 patients endorsed the use of at-home spirometry as an adherence intervention, PMD reported. Almost 95% of patients were adherent to the Spiro PD device.

Medication reminders from the company’s Spiro PD device were identified as an adherence motivator, according to PMD. Overall, pulmonary function tests, body mass index and treatment burden scores improved in the intervention group compared to the control group.

“This study offers further evidence of how remote patient monitoring and supportive adherence reminders, can have a positive impact on patient self- management and play a pivotal role in treatment success,” executive VP Steve Sullivan said in prepared remarks.

Spiro PD, which PMD touts as the 1st personal spirometer, won FDA approval in 2011. The company said it is launching the 2nd-generation device, Spiro PD 2.0, and its Wellness Management System to connect patients and caregivers using telemonitoring technology.

Filed Under: Clinical Trials, Featured, Patient Monitoring, Wall Street Beat Tagged With: pmd healthcare

IN CASE YOU MISSED IT

  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS